PLOSMedicine: RT @MHTF: Effect of Facilitation of Local Maternal-and-Newborn Stakeholder Groups on Neonatal Mortality http://t.co/b1ofFDDMD9 @PLOSMedicine
PLOSPathogens: Very excited for the beginning of #KSimmunity today in Ouro Preto. Make sure to say hello if you see anyone with a PLOS button!
PLoSNTDs: Stinky socks attract P. falciparum-infected An. gambiae? So states new report in @PLOSONE via @latimesscience
http://t.co/pWXLV6lusz
-
Image Credit: Alberto G.
Blog Archives
MSF Scientific Day 2013
Category: Conference news, General, MSF
Tagged Africa, developing world, global health, MSF
1 Comment
Seasonal Malaria Chemoprevention: Good News in a Year Marked by Malaria Emergencies
Category: General, MSF
Tagged Africa, antimicrobial drugs, developing world, global health, malaria, MSF, public health, sub-saharan Africa
4 Comments
Vaccines in Developing Countries: Why the High Prices?
Category: MSF
Tagged developing world, global health, health policy, MSF, pharmaceutical industry, Vaccines
Leave a comment
Familiar Enemies in Conflict and TB
Category: MSF
Tagged Africa, antimicrobial drugs, HIV, HIV/AIDS, MSF, sub-saharan Africa, tuberculosis
Leave a comment
Buruli Ulcer in a Brave New World
Category: General, MSF, Neglected Diseases
Tagged Africa, developing world, global health, MSF, neglected tropical diseases
Leave a comment
Stuck in a time warp: WHO-brokered global R&D action plan shelved
Category: Access, MSF, Neglected Diseases
Tagged developing world, global burden of disease, global health, MSF, neglected tropical diseases, WHO
Leave a comment
Children with TB – Global Interest at Last
Category: General, MSF
Tagged antimicrobial drugs, developing world, global health, MSF, tuberculosis
Leave a comment
Gathering the Evidence to Improve Health Care in Developing Countries: Meta-analysis without Borders
Category: General, MSF
Tagged Africa, antiretroviral treatment, developing world, global burden of disease, guidelines, HIV, HIV/AIDS, MSF
Leave a comment
India’s patent law on trial
Category: General, MSF
Tagged global health, health costs, health policy, MSF, pharmaceutical industry
4 Comments